Delivery Order SPE2DB22D1103-SPE2DB24FTEQ9
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,502.44 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this delivery order, which is not associated with any set-aside program. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,177.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical company. The contract, which has a completion date of February 2, 2024, is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, holds an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The order has a potential value of $6,306.96 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,177.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 3 mg/0.5 mL TRULICITY pens. This delivery order contract was issued under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $13,933.44 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which is part...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,752.17 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,161.12 contract is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,741.68 contract is for the supply of the medication TRULICITY 3 MG/0.5 ML PEN 0.5ML, with a period of performance through February 8, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,451.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order is for the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, with a completion date of February 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, awarded solely to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $19,739.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEQ9Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,177.10 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. This contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not designated as a set-aside contract. Additionally, AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/1/24 |